MAGEL2

MAGE family member L2, the group of MAGE family

Basic information

Region (hg38): 15:23643549-23647867

Previous symbols: [ "NDNL1" ]

Links

ENSG00000254585NCBI:54551OMIM:605283HGNC:6814Uniprot:Q9UJ55AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Schaaf-Yang syndrome (Definitive), mode of inheritance: Autosomal dominant inheritance with maternal imprinting HP:0012275
  • Schaaf-Yang syndrome (Strong), mode of inheritance: AD
  • Schaaf-Yang syndrome (Definitive), mode of inheritance: AD
  • Schaaf-Yang syndrome (Definitive), mode of inheritance: AD
  • Schaaf-Yang syndrome (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Schaaf-Yang syndrome (Prader-Willi-like syndrome)ADEndocrineThe condition has been described as including neonatal hyperinsulinemia hypoglycemia, and awareness may allow prompt managementCraniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic24076603; 25473036; 26365340; 27195816; 28281571

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MAGEL2 gene.

  • not provided (20 variants)
  • Schaaf-Yang syndrome (16 variants)
  • Inborn genetic diseases (5 variants)
  • Prader-Willi syndrome (2 variants)
  • Generalized hypotonia;Ventriculomegaly;Multiple joint contractures;Ambiguous genitalia (1 variants)
  • Schaaf-Yang syndrome;Prader-Willi-like syndrome (1 variants)
  • Developmental disorder (1 variants)
  • Neurodevelopmental disorder (1 variants)
  • Neurodevelopmental delay (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAGEL2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
33
clinvar
163
clinvar
11
clinvar
207
missense
1
clinvar
450
clinvar
43
clinvar
7
clinvar
501
nonsense
14
clinvar
11
clinvar
3
clinvar
28
start loss
1
clinvar
1
frameshift
22
clinvar
18
clinvar
3
clinvar
43
inframe indel
41
clinvar
6
clinvar
47
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
2
clinvar
3
Total 37 30 531 212 20

Variants in MAGEL2

This is a list of pathogenic ClinVar variants found in the MAGEL2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-23643744-A-T Benign (Jul 09, 2018)1233500
15-23643886-G-T Benign (Jul 09, 2018)1252492
15-23643995-A-T Uncertain significance (Apr 01, 2023)2805099
15-23643997-C-T MAGEL2-related disorder Conflicting classifications of pathogenicity (Aug 28, 2023)235292
15-23643998-G-A Uncertain significance (Jun 15, 2023)2644975
15-23643998-G-C Uncertain significance (Jul 26, 2023)2959687
15-23644003-G-A Uncertain significance (Jan 03, 2023)1810580
15-23644004-G-C Inborn genetic diseases Uncertain significance (Aug 28, 2023)2622050
15-23644015-G-A Uncertain significance (Dec 05, 2022)2805279
15-23644016-T-C Schaaf-Yang syndrome Uncertain significance (Aug 01, 2022)2428911
15-23644020-G-T Uncertain significance (May 08, 2023)2023408
15-23644022-C-T Benign/Likely benign (Nov 24, 2023)735029
15-23644023-G-T Schaaf-Yang syndrome Uncertain significance (Feb 14, 2023)2689392
15-23644026-G-T Likely benign (Jun 04, 2022)1944396
15-23644030-C-T MAGEL2-related disorder Uncertain significance (May 21, 2024)3344586
15-23644037-C-T MAGEL2-related disorder Uncertain significance (Dec 11, 2023)2062231
15-23644038-G-C Likely benign (Apr 18, 2022)739279
15-23644039-G-T MAGEL2-related disorder Uncertain significance (Oct 16, 2022)2634562
15-23644040-T-G Inborn genetic diseases Uncertain significance (Jun 16, 2024)3292697
15-23644041-G-GTCA MAGEL2-related disorder Uncertain significance (Sep 04, 2024)1048991
15-23644049-C-T MAGEL2-related disorder Uncertain significance (Mar 12, 2024)3355746
15-23644053-C-G not specified Conflicting classifications of pathogenicity (Feb 01, 2024)287995
15-23644060-G-A Uncertain significance (Jul 22, 2021)1369366
15-23644067-C-G Inborn genetic diseases Uncertain significance (Jan 08, 2024)3122226
15-23644072-T-C Uncertain significance (Sep 01, 2023)2644976

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MAGEL2protein_codingprotein_codingENST00000532292 12485
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9750.024900000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5633993691.080.00002094145
Missense in Polyphen7673.1311.0392861
Synonymous-1.721851581.170.000009411352
Loss of Function3.75220.20.09920.00000112209

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Acts as a regulator of retrograde transport via its interaction with VPS35. Recruited to retromer-containing endosomes and promotes the formation of 'Lys- 63'-linked polyubiquitin chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote endosomal F-actin assembly (PubMed:23452853). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Significantly promotes the cytoplasmic accumulation of CLOCK (By similarity). {ECO:0000250|UniProtKB:Q9QZ04, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:23452853}.;
Pathway
Circadian rythm related genes;Prader-Willi and Angelman Syndrome (Consensus)

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.293
ghis
0.463

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Magel2
Phenotype
muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; taste/olfaction phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;

Gene ontology

Biological process
Arp2/3 complex-mediated actin nucleation;retrograde transport, endosome to Golgi;regulation of circadian rhythm;negative regulation of transcription, DNA-templated;rhythmic process;protein K63-linked ubiquitination
Cellular component
nucleus;endosome;early endosome;cytosol;retromer complex
Molecular function
ubiquitin-protein transferase activity;protein binding